Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
Cell and Gene Therapy, Biologics, Cancer
Your cell counts will never be perfect – here’s why.
September 26, 2024 -
6 min read
Cell and Gene Therapy, Biologics, Cancer
Understanding autophagy.
September 25, 2024 -
2 min read
Cell and Gene Therapy, Biologics, Cancer
Is your Trypan blue rupturing dead or dying immune cells leading to an overestimation of cell viability?
September 25, 2024 -
10 min read
Biologics
Microfluidic electrophoresis for nucleic acid and protein analysis.
September 25, 2024 -
3 min read
Cell and Gene Therapy, Biologics, Cancer
How to count cells using a hemocytometer.
September 13, 2024 -
1 min read
Biologics
White paper: screening and characterization of multi-specific antibody therapeutics.
June 24, 2024 -
2 min read
Biologics
Offsetting COVID-19 staffing limitations in a laboratory: improving workflow efficiency via shorter assay workflows.
June 24, 2024 -
3 min read
Cell and Gene Therapy, Biologics, Small Molecule Drug Discovery
The evolving role of cell counting in drug discovery.
May 30, 2024 -
2 min read
Biologics
Challenges and strategies for characterization of next-generation bispecific antibodies.
May 24, 2024 -
3 min read
